EventsThe 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S9. Formulation, Drug Delivery, and Controlled Release of the event The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
28 Oct, 2026
Academic Editor
author-avatarAlfredo Berzal-Herranz
Contribution&Funding
Conceptualization,
[Carmo Ferreira Correia] ; [Ana Rita Favas] ; [Domingos Ferreira] ; [Ana Catarina Silva]
Methodology,
[Carmo Ferreira Correia]
Writing - original draft,
[Carmo Ferreira Correia]
Writing - review,
[editing] ; [Ana Catarina Silva]
Funding: This work received financial support through PT national funds COMPETE2030-FEDER-01199900, through Portugal 2030 and FEDER, in the scope of the project “Shrimp4NanoCosmetics”.
Citation
Carmo Ferreira Correia, Ana Rita Favas, Domingos Ferreira, Ana Catarina Silva, From bench to 500 mL: scale-up and characterization of nanostructured lipid carriers, in Proceedings of The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

From bench to 500 mL: scale-up and characterization of nanostructured lipid carriers

Carmo Ferreira Correia 1,2
Domingos Ferreira 1,2
image
1. UCIBIO, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy of the University of Porto, Porto, 4050-313, Portugal
2. Associate Laboratory i4HB Institute for Health and Bioeconomy, Faculty of Pharmacy of the University of Porto, Porto, 4050-313, Portugal
3. FP-I3ID (Institute for Research, Innovation and Development), FP-BHS (Biomedical and Health Sciences Research Unit), Faculty of Health Sciences, University Fernando Pessoa, , Porto, 4200-150, Portugal
Abstract

Nanostructured lipid carriers (NLCs) are effective vehicles for prolonged drug delivery, although scalable production methods are needed for commercial applications [1-3]. Increasing the formulation volume can affect particle size (PS) and polydispersity index (PDI), potentially compromising stability [2, 4].

In this work, NLC formulations were prepared in volumes ranging from 20 to 500 mL volumes and the process parameters were optimised to maintain a small PS and low PDI. NLCs were prepared using the ultrasound method described by Silva et al. [5]. Lipid and aqueous phases were heated and homogenised, and the resulting oil-in-water emulsion was sonicated and cooled to form the NLCs. The starting formulation was sonicated using a VCX 130 ultrasonic processor at 50% amplitude for 20 min, whereas the large-scale formulations were prepared using a Sonoplus® HD 4400, combining different amplitudes (20 and 50%) with different sonication times (5 to 20 min). PS and PDI were measured by dynamic light scattering (n=3, 25 ºC). 

At 20 mL, the PS was 82.5 ± 0.4 nm and the PDI was 0.226 ± 0.010. Among all combinations tested at the 500 mL scale, sonication at 20% amplitude for 15 min resulted in the smallest PS (107.8 ± 1.0 nm) and the lowest PDI (0.232 ± 0.008). Overall, appropriate adaptation of the process parameters and equipment enabled NLC production at the 500 mL scale while maintaining PS and PDI comparable to those of the small-scale formulation.

Keywords
Scale-up
Nanostructured lipid carriers
Lipid nanoparticles
Polycation-stabilized alginate-based hydrogels for the regeneration of skin and mucous membranes
Biofunctional Polymer-Based Platforms for Controlled Delivery of STING Inhibitors